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ABSTRACT: The Wnt/β-catenin signaling pathway is critical to embryonic development as well as adult tissue
regeneration. Dysregulation of this pathway can lead to a variety of human diseases, in particular cancers.
Chibby (Cby), a small and highly conserved protein, plays an antagonistic role in Wnt signaling by inhibiting
the binding of β-catenin to Tcf/Lef family proteins, a protein interaction that is essential for the
transcriptional activation of Wnt target genes. Cby is also involved in regulating intracellular distribution
of β-catenin. Phosphorylated Cby forms a ternary complex with 14-3-3 protein and β-catenin, facilitating the
export of β-catenin from the nucleus. On the other hand, the antagonistic function of Cby is inhibited upon
binding to thyroid cancer-1 (TC-1). To dissect the structure-function relationship of Cby, we have used
NMR spectroscopy, ESI-MS, CD, and DLS to extensively characterize the structure of human Cby. Our
results show that the 126-residue Cby is partially disordered under nondenaturing conditions. While the
N-terminal portion of the protein is predominantly unstructured in solution, the C-terminal half of Cby
adopts a coiled-coil structure through self-association. Initial data for the binding studies of Cby to 14-3-3ζ
(one of the isoforms in the 14-3-3 family) and TC-1 via these two distinct structural modules have also been
obtained. It is noteworthy that in a recent large-scale analysis of the intrinsically disordered proteome of
mouse, a substantial number of disordered proteins are predicted to have coiled-coil motif presence in their
sequences. The combination of these two molecular recognition features could facilitate disordered Cby in
assembling protein complexes via different modes of interaction.
The molecular mechanism of Wnt/β-catenin signaling has
been intensively investigated in the past 2 decades because of
the pivotal role this pathway plays in development processes and
its association with human diseases, in particular cancers (1-4).
Being a key protein in this signaling pathway, the level and
intracellular distribution of β-catenin are tightly regulated by
different mechanisms. In the absence of Wnt signal, β-catenin in
cytosol is phosphorylated at multiple Ser/Thr sites located in its
N-terminal domain by the destruction complex composed of
axin, adenomatous polyposis coli (APC),
1 glycogen synthase
kinase-3β (GSK-3β), and casein kinase 1 (CK1) [reviewed in
Kimelman and Wu (5)]. The phosphorylated β-catenin is subse-
quentlyubiquitinatedandtargetedforproteasomaldegradation(6).
In the presence of the Wnt signal, however, the phosphorylation
of β-catenin by the destruction complex is inhibited. The
accumulationof hypophosphorylated β-catenininthe cytoplasm
provokes the protein translocation to the nucleus, where it
interacts with T cell factors (Tcf)/lymphoid enhancer factor
(Lef) proteins to activate the transcription of Wnt target genes,
with many of them being involved in cell proliferation (7).
Because of its strong link to cancers, targeted inhibition of Wnt/
β-cateninsignalingbecomesanactiveresearchareaintherapeutic
development (8).
Oneofthekeybindingpartnersofβ-cateninisChibby(Cby),a
small (126 residues in human) and highly conserved protein,
which was first identified as an antagonist of Wnt signaling in
2003 (9). It functions by competing with the Tcf/Lef family of
proteins for binding to β-catenin (9). Besides functioning as an
inhibitor of β-catenin-Tcf binding, in a recent study, Takemaru
and co-workers demonstrated that Cby also plays an essential
role in the intracellular distribution of β-catenin in conjunction
with 14-3-3 (10), a family of proteins that function in a variety of
signaling pathways by interacting with phosphorylated Ser/Thr
targets (11-13). With a canonical mode II binding motif of
14-3-3 harbored in its N-terminal region between residues
16-22 (11-13), it has been shown that Cby can form a ternary
complex with 14-3-3ζ and β-catenin in the nucleus upon phos-
phorylation at S20 by Akt1. This complex formation facilitates
the export of β-catenin to the cytoplasm, which in turn
diminishes Wnt signaling (10, 14).
Cby has also been showntobind tothyroidcancer-1 (TC-1),a
tumorigenic and intrinsically disordered protein first found to be
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upregulated in thyroid cancer cells (15, 16). Being a positive
regulator in Wnt signaling, TC-1 interacts with Cby and inhibits
its binding to β-catenin (17), which in turn leads to upregulation
of many cancer-associated genes. Structural characterization of
TC-1 by nuclear magnetic resonance (NMR) shows that the
protein is partially disordered (16, 18). While the N-terminal
portion of the protein is largely unstructured, three segments of
the protein in the C-terminal half are found to contain high
helical propensity. Importantly, these preformed structural ele-
ments in TC-1 are involved in mediating its interaction with
Cby (18).
Because of the crucial role Cby plays in the Wnt/β-catenin
signaling pathway, it is not surprising that Cby is associated with
different human diseases (19-22). For instance, Schuierer et al.
discovered that the mRNA of Cby is downregulated in colon
carcinoma cell lines (20). On the other hand, Singh et al.
demonstrated thatoverexpressionofCbyisrelated to the cardiac
differentiation of embryonic stem cells (21). Further, Cby has
also been found to be involved in polycystic kidney disease (23).
By using the yeast two-hybrid screening technique, in 2004,
Hidaka et al. identified Cby (the authors named the protein
PIGEA-14; polycystin-2 interactor, Golgi- and endoplasmic
reticulum-associated protein with a molecular weight of 14 kDa)
as a binding target of polycystin-2, a protein that has been found
tobemutatedinsomepatientswithpolycystickidneydisease(23).
The interaction between PIGEA-14/Cby and polycystin-2 is
shown to be crucial in regulating the intracellular distribution
of the latter (23).
Despite the fact that multiple binding partners of Cby have
been identified,structuralinformation ofCbyisstilllimited.This
hinders a detailed understanding of the molecular mechanism by
which Cby interacts withits targets. For instance, the 781-residue
human β-catenin consists of a core armadillo repeat region
(residues 138-664) flanked by the highly unstructured N- and
C-terminal domains (24, 25). Consisting of 12 repeats and with
each of these repeats composed of three R-helices (except for
repeat 7, which has only two R-helices), the armadillo region
adopts an elongated, superhelical structure with a positively
charged groove, providing a large accessible surface area for
protein-protein interactions (24, 25). Crystal structures of the
β-catenin/Tcf complex reveal that the disordered Tcf4 adopts an
elongated structure upon binding to the positively charged
groove of the armadillo region of β-catenin, spanning repeats
3-9( 26-28). On the other hand, by using a yeast Ras recruit-
ment system and differenttruncated β-cateninconstructsasbaits
for target screening, Takemaru et al. discovered that Cby binds
specifically to the armadillo repeats 10-12 and the C-terminal
region of β-catenin via its C-terminal half, which is predicted to
contain a coiled-coil motif (9, 14, 23). Interestingly, even though
Cby competes with Tcf4 to bind to β-catenin, the binding sites of
these two proteins on β-catenin do not overlap.
Inthepresentwork,wehavecarriedoutanextensivestructural
characterization of Cby using NMRspectroscopy,CD, ESI-MS,
andDLS.OurresultsdemonstratethatCby,thebindingtargetof
TC-1, β-catenin, and 14-3-3ζ in the Wnt/β-catenin pathway, is
partially disordered in its free state. The NMR and CD data
together suggest that the N-terminus of Cby, which has been
shown to mediate the interaction with 14-3-3ζ upon phosphor-
ylation(10),islargelyunstructuredintheabsenceofitstarget.On
theotherhand,theC-terminalportionofCby,whichharborsthe
bindingsitesofTC-1andβ-catenin,islikelytoadoptacoiled-coil
conformation that is highly stable even in the presence of 4 M urea.
This potential coiled-coil domain is found to have a high
tendency to self-associate, which renders the structural charac-
terization of this region challenging (29). The biological implica-
tionsofthecoexistenceofthesetwodistinctstructuralmodulesin
Cby are appraised in the Discussion.
EXPERIMENTAL PROCEDURES
ProteinSample Preparation. The pDEST17 plasmid carry-
ingthehumanCbycDNAsequencewiththeN-terminalHis6-tag
was transformedinto the Rosetta 2(DE3)pLysS strain of Escher-
ichia coli (Novagen) for protein overexpression. For
15N,
13C-
labeled protein samples, cells were grown at 37 Ci n1Lo fM 9
m e d i ac u l t u r ec o n t a i n i n g1go f
15NH4Cl (Cambridge Isotope
Laboratories) and 3 g of
13C6-D-glucose (Isotec) as the only
nitrogen and carbon sources, respectively, until the OD600 value
reached 0.7-0.8. CaCl2 (0.1 mM), 1 mM MgSO4,1 0μg/mL of
thiamin, and 10 μg/mL of biotin were also added to the media as
supplements. The protein overexpression was then induced with
0.5 mM isopropyl β-D-thiogalactopyranoside (IPTG; BioShop),
and the cells were allowed to grow overnight at 18 C before
harvesting. The cells were lysed by sonication (with lysozyme
added) and followed by centrifugation at 16000g to sediment the
inclusion bodies. The washed inclusion bodies were then solubi-
lized in 8 M urea, and the resulting solution was mixed in a 1:4
volume ratio with an 8 M urea binding buffer (20 mM Tris,
pH 7.5, 5 mM imidazole, 500 mM NaCl, and 8 M urea).
Nickel Sepharose (GE Healthcare) beads pre-equilibrated with
thebindingbufferwerethenadded,andthemixturewasincubated
at room temperature for 2 h on a rotator. The beads were loaded
to an econocolumn and washed extensively with 8 M urea
binding buffer. The protein was subsequently eluted with buffer
containing 8 M urea and 1 M imidazole and then dialyzed
overnight into a buffer with8 M urea and10 mMsodium acetate
at pH 5. Finally, the urea was removed by dialysis, with the final
buffer for the protein containing 10 mM sodium acetate at pH
5.0. The purity of the protein was confirmed both by SDS-
PAGE gel electrophoresis and ESI-MS. The protein yield was
∼30 mg/L of growth. The 29-residue His6-tag sequence contain-
ing a tobacco etch virus cleavage site was retained in the experi-
ments since the removal of the tag significantly reduced the
solubility of the protein.
Site-Directed Mutagenesis of Wild-Type Human Cby.
Wild-type human Cby in pDEST17 plasmid was subjected to
point mutagenesis using the Stratagene QuikChange II site-
directed mutagenesis kit. Overexpression and purification of
mutational variants were carried out with the similar procedure
as mentioned above for the wild-type human Cby.
Electrospray Ionization Mass Spectrometry. ESI-MS
data were recorded on a Q-TOF spectrometer (Micromass) in
positive ion nanospray mode. The cone voltage was 50 V, with a
source temperature of 80 C. Calibration of the instrument was
performed with myoglobin. The experiment was performed
under nondenaturing conditions with the buffer of 10 mM ammo-
nium acetate at pH 5. Protein concentrations ranging from ∼20 to
50 μM were used. All data were acquired and analyzed using
MassLynx software provided by the instrument manufacturer.
Circular Dichroism Spectropolarimetry. CD experiments
were performed on a Jasco J-810 spectropolarimeter (Easton,
MD), equipped with a PTC-423S Peltier temperature control
unit, using a cuvette with 0.1 mm path length. The wavelength
was calibrated using neodymium glass, and the CD signal wasArticle Biochemistry, Vol. 50, No. 5, 2011 717
calibrated using ammonium d-10-camphorsulfonate. Both cali-
brations were carried out as described in the Jasco Model J-810
Spectropolarimeter Hardware/Function Manual. Spectra of
40 μM Cby (190-260 nm, in 10 mM sodium acetate at various
pH values as well as various additives such as urea; see Results
section) were recorded at 25 C. For the melting curves of Cby,
the temperature was scanned from 5 to 100 C, and the ellipticity
at 222 nm was monitored. All data sets were collected using
Spectra Manager software, and the CD data (θ, in millidegrees)
were converted to mean residue ellipticity ([θ]) using standard
formula and the software supplied by the manufacturer. The
programs SELCON3, CDSSTR, and CONTIN/LL included in
the CDPro software package were used to deconvolute the CD
spectra (30). A wavelength range of 190-240 nm and reference
sets SMP56 and SDP48 were used in the calculations.
DynamicLightScattering.TheStokesradiiofthewild-type
Cby and its mutants were measured using the ALV/CGS-3
compact goniometer system at room temperature, with a laser
sourceof22mW(ALV/LSE-S003).Proteinsamples(inrangesof
50μMandabove)werepreparedin10mMsodiumacetatebuffer
at pH 5.0, and all samples and buffers were filtered through a
0.2 μm filter prior to analysis to prevent interference from
residual particulates. Lysozyme was used as the control protein.
The refractive indexof the10 mMpH 5 acetatebuffer was found
tobeclosetowater,and thus,theηvalue usedwasleftasdefault.
Each measurement was repeated two to three times (30 s
acquisition intervals each), and all data were processed using
ALV correlator software (version 3.0). The mass-averaged
method, a built-in function of the ALV correlator software, was
used to calculate the hydrodynamic radii of different protein
samples. Since particles large in size scatter light more efficiently
thansmallparticlesinDLS,evenatraceamountoflargeparticles
(i.e., dust) can contribute significantly to the light scattering.
The built-in mass-averaged function was used to correct this
bias (31, 32).
NMR Spectroscopy. Five heteronuclear triple resonance
experiments, HNCACB, CBCA(CO)NH, C(CO)NH, HN-
(CA)CO, and HNCO (33-35), were recorded for backbone
resonance assignments.
13C,
15N-labeled protein samples (250-
300 μM) in 10 mM sodium acetate at pH 5.0 in the presence of
different concentrations of urea were used, and the experiments
were performed on a Varian Inova 600 MHz spectrometer
equipped with a xyz-gradient triple resonance probe (UWO
Biomolecular NMR Facility) at 25 C.
1H-
15N TROSY-HSQC
spectra of
13C,
15N,
2H-labeled Cby (∼200 μM) in 10 mM sodium
acetate at pH 5.0 were also acquired at 25 C on a Varian Inova
600MHz spectrometer (UWO Biomolecular NMRFacility) and
aVarianInova800MHzspectrometer(CanadianNationalHigh
FieldNMRCentre), both equipped witha Z-gradient HCNcold
probe. All chemical shifts were referenced to the internal DSS
(2,2-dimethyl-2-silapentane-5-sulfonate) signal. Data were pro-
cessed and analyzed using the programs NMRPipe (36)a n d
NMRView (37).
Hydrodynamic radius (Rh) measurement by NMR was per-
formed using the water-suppressed longitudinal encode-decode
(water-sLED) pulse sequence on a sample with 360 μM N-Cby-
(S20D) and9mM1,4-dioxanewitharangeofgradientstrengths,
G (38). The decay rates (D) of the protein and dioxane signals (I)
were determined individually based on the linear plot of
log(I)v e r s u sG
2,a sI(G)=A exp(-DG
2). The Rh of the pro-
tein was then calculated based on the signal decaying rates of
protein (Dprotein) and dioxane (Ddioxane) using the equation
Rh =( Ddioxane/Dprotein)   2.12 A ˚ , proposed by Wilkins et al. (39).
The experiment was recorded three times, and protein signals
from backbone amide, side-chain amide, and aliphatic regions
were used to calculate the averaged values of Dprotein.
Backbone
15NR1andR1Fexperiments(40,41)wereperformed
on
15N-labeled N-Cby(∼200μM)andN-Cby(S20D) (∼360μM)
samples in 10 mM acetate buffer at pH 5.0, using sequences
included in the Varian Biopack library. A series of relaxation
delay times (t) between 10 and 640 ms were used in the R1
experiments, while delay times ranging from 10 to 150 ms were
used intheR1Fmeasurements. The R1 and R1Frelaxation rates of
assigned signals that are well-resolved were determined based on
the attenuations of peak intensity versus relaxation times, which
follow the equation I(t)=I(0) exp(-Rt), where I(t)i st h ep e a k
intensity at relax time t. Errors in the relaxation rates were
estimated based on the fits of the data. The transverse relaxation
rate, R2, was then calculated on the basis of the observed R1 and
R1F values, and the offset between the resonance and the carrier
frequency (Δω) in hertz, using the equation
R2 ¼ð R1F -R1 cos2 θÞ=sin
2 θ
where tan θ = BSL/Δω. BSL (=1.5 kHz) is the spin-lock field
used in the R1F experiments (42).
Steady-state
1H-
15NNOEvaluesweredeterminedastheratio
of the peak intensities derived from the spectra acquired in the
presence and the absence of
1H saturation (41). A 7 s delay
between scans followed by 5 s of saturation period was used in
recording the
1H-
15N NOE with proton saturation, while a 12 s
delay between scans was used for
1H-
15N NOE without satura-
tion. Errors were estimated on the basis of the signal-to-noise
ratios of individual peaks.
To probe the interaction between
15N-labeled N-Cby(S20D)
and unlabeled 14-3-3ζ, the following procedure was used for the
NMR sample preparations.
15N-labeled N-Cby(S20D) (∼200 μM)
in 10 mM sodium acetate buffer, 1 mM DTT, and 1 mM EDTA
at pH 5.0 was mixed rapidly in a 1:1 (v/v) ratio with the buffer
(250 mM NaCl, 50 mM Tris, 1 mM DTT, and 1 mM EDTA, at
pH 7.0) containing either 0 (as the control) or ∼600 μM 14-3-3ζ.
The pH of the final solutions were adjusted to 7.0 by adding small
amounts of 50 mM NaOH (∼40 μL). Precipitated proteins were
removed by centrifugation before the NMR experiments were
performed.
RESULTS
Protein Sequence Analysis. Protein sequence analysis
shows that Cby is highly conserved across a range of organisms
spanning from fly to zebrafish, mouse, and human (9). Although
limited structural informationof human Cby isavailable to date,
bioinformatic analysis predicts that a coiled-coil domain with
four heptad repeats is located at the C-terminal part of the protein
(residues 73-100; Figure 1a and Supporting Information Figure S1)
(9, 23, 29, 43). Meanwhile, amino acid composition analysis
showsthatoverallCbyisricherinchargedandpolarresiduesand
is mildly deficient in hydrophobic amino acids compared to
globular proteins, despite a high number of leucine residues
present in the predicted coiled-coil region. This unique composi-
tion places Cby on the borderline between ordered and disor-
dered proteins in the charge-hydropathy plots (Supporting
Information Figure S2b-d) based on the analysis proposed by
Uversky et al. (44). The protein is also predicted to be largely
disorderedbyPONDR(predictorofnaturallydisorderedregion;718 Biochemistry, Vol. 50, No. 5, 2011 Mokhtarzada et al.
Supporting Information Figure S2a), one of the most commonly
used predictors for disordered proteins (44-47), as a significant
number ofresidues inthe proteinhave PONDR scores above the
threshold of 0.5.
Cby Is Partially Disordered. In order to identify the
residue-specific structure of Cby, extensive structural character-
izationoftheproteinwascarriedoutbyNMRspectroscopy.Due
to the high tendency of sample precipitation at pH >5 or at high
salt concentration (more discussion below), sample buffer with
10 mM sodium acetate at pH 5 was used for the NMR studies
unless otherwise specified. Figure 2a shows the
1H-
15N HSQC
spectrum of Cby. The lack of chemical shift dispersion (crowded
inarangeof7.6-8.8ppmin
1Hdimension)ofpeakssuggeststhat
at least a significant portion of the protein is disordered.
Intriguingly, the number of peaks in the spectrum is less than
50% of what is expected to be observed for the full-length Cby.
The secondary structures of Cby were also characterized by CD
spectropolarimetry (Figure 1b). To quantitatively determine the
secondary structure contents of Cby, measured CD spectra were
deconvolutedusingtheCDProsoftware(30). Theresult indicates
that Cby contains 43 ( 2% of helical, 10 ( 1% of β-strand, and
47( 3% of random coil/turnstructures in10 mM acetatebuffer,
atpH5.IfweassumethattheHis-tagresiduesareinrandomcoil
conformations, the deconvolution result reveals that ∼67 resi-
duesofCbyareinhelicalconformationwhile∼44residuesadopt
random coil/turn structures. This clearly demonstrates that Cby
is partially disordered yet with a high helical content present in
the protein.
To obtain residue-specific structural information of Cby,
heteronuclear three-dimensional NMR experiments were per-
formed for the backbone resonance assignment of the protein.
The result indicates that most of the peaks that are observed in
the
1H-
15N HSQC spectrum of full-length Cby originate from
the N-terminal portion of the protein (Figure 2a). This was
further confirmed by the NMR analysis of the truncated Cby
construct, which contains only the N-terminal half of the protein
(N-Cby; residues 1-63). The fact that the majority of peaks
observed in the
1H-
15N HSQC of N-Cby can essentially overlay
with the peaks observed in the spectrum of full-length Cby
(except for residues 50-63) suggests that at least a large portion
of the N-terminal part of the protein is disordered and may not
interact significantly with the C-terminal segment (Figure 2b).
The disordered nature of N-Cby is also confirmed by CD
spectropolarimetry. The CD spectrum of N-Cby (Figure 7b)
displays a large and negative signal at 190 nm and negligible
ellipticities at 208 and 222 nm, indicating that N-Cby is largely
unstructured (48). Interestingly, deconvoluted CD data reveal
thatN-Cbycontainsonly5(2%ofhelical,27(7%ofβ-strand,
and68(7%ofrandomcoil/turnstructures.ThefactthatN-Cby
contains significantly less helical content compared to the full-
length Cby (5% vs 43%) strongly suggests that the helical
structures of Cby are located at the C-terminal portion of the
protein, which is predicted to adopt a coiled-coil conformation.
The residue-specific secondary structure propensities of Cby
werethen determinedbyusing the SSPprogram. SSP (secondary
structurepropensity) isamethoddevelopedbyForman-Kayand
co-workers to determine the residue-specific secondary structure
propensity of IDPs based on their measured chemical shifts (49).
In brief, the SSP score of a residue can be interpreted as the
expected fraction of R-helical or β-strand/extended structure
(a residue with fully formed R-o rβ-structure will have an SSP
score of 1 or -1, respectively). For instance, a SSP score of 0.3
can be interpreted as 30% of the conformers in the disordered
state ensemble adopt helical dihedral angles at that particular
position (49). Secondary structure chemical shifts for different
FIGURE 1: (a) Schematic diagram of the Cby primary structure. The
canonical mode II binding motif of 14-3-3 is underlined. Negatively
and positively charged residues are colored in red and blue, respec-
tively.Thearrowsindicatethelocationofmutationsites.(b)Far-UV
CD spectra of Cby recorded at pH 3 (blue), 4 (magenta), 5 (green),
and 6 (black). The data were collected at 25 C.
FIGURE 2: (a)Assigned
1H-
15NHSQCspectraoffull-lengthCbyin10mMsodiumacetate,pH5.(b)OverlayoftheHSQCspectraoffull-length
Cby (blue) and N-Cby (red), in 10 mM sodium acetate, pH 5.Article Biochemistry, Vol. 50, No. 5, 2011 719
aminoacidtypesinwell-foldedproteinsaretakenintoconsidera-
tion in the calculation, and the relative secondary chemical shifts
of
13CRand
13Cβatomsareusedtocorrectforpotentialchemical
shiftreferencingerror(49-52).Sincemostofthesignalsfromthe
C-terminal half of Cby are unobservable, the SSP analysis was
focused on the N-terminal portion of the protein. The result
reveals that even though no stable secondary structure exists in
the N-terminal region of the full-length Cby, a notable helical
propensityispresentbetweenresidues20and50,eventhoughitis
lesssignificantcomparedtoresidues73and74,whicharelocated
at the beginning of the predicted coiled-coil region of the protein
(Figure 3a). This helical propensity is shown to decrease as the
concentration of urea increases (Figure 3b). Based on the SSP
analysis, the rest of the N-terminal portion of Cby adopts
β-strand/extended structure (with SSP score <0), which is more
pronounced in the presence of denaturant (i.e., 4 M urea).
Stable Helical Content Exists in the C-Terminal Part of
Cby. Despite the NMR signals originating from the C-terminal
regionofCbybeingunobservable,theCDdataoffull-lengthCby
(Figure 1b) and N-Cby (Figure 7b) together provide strong
evidencethathelicalstructureispresentintheC-terminalportion
of the protein. Further, this helical structure is stable over a wide
pHrange(Figure 1b) or inthe presenceofhigh concentrationsof
denaturant (up to 4 M urea; Supporting Information Figure S3).
Figure1balsoshowsthatwhiletheCDspectraofCbyatpH3-6
display no dramatic difference, the ratio of the ellipticities at 222
and208 nm ([θ]222/[θ]208)becomescloserto1asthepHincreases,
which suggests that the coiled-coil interaction may exist in the
C-terminal portion of Cby and it becomes more stable at higher
pH (53).
Self-Association of Cby via the C-Terminal Coiled Coil.
The coiled-coil interaction may also explain the strong self-
association tendency of Cby at high pH and salt concentration.
For instance, the 18 kDa Cby elutes as a broad peak at ∼79 kDa
from a size-exclusion column when 10 mM acetate (pH 5) with
100 mM NaCl was used as the buffer. Results of sedimentation
velocity (data not shown) also indicate that the apparent
molecular weight of Cby increases as the salt concentration of
the buffer increases. The self-association of Cby has also been
investigated using nondenaturing ESI-MS. The ESI-MS result
shown in Figure 4 indicates that in a buffer with only 10 mM
ammonium acetate at pH 5 (similar tothe buffer conditions used
in the NMR studies) Cby exists as a mixtureof monomer, dimer,
and tetramer. However, we should point out that the ESI-MS
datacould onlybe interpreted qualitatively. They cannotbe used
to quantify the populations of monomer and dimer since the
ionizationefficiencyofthe lattercanbe significantly lowerdueto
the reduction in exposed hydrophobic surface area (54, 55). We
have also measured the averaged hydrodynamic radius (Rs)o f
Cby using dynamic light scattering. The result shows that the Rs
of Cby is ∼30 A ˚ , which is significantly larger than a globular
proteinwithsimilarmolecularweight.Eventhoughthelargevalue
of Rs can be due to dimerization, partial unfolding, or formation
of elongated coiled-coil structure of Cby, the ESI-MS and DLS
results together strongly suggest the existence of oligomers in the
ensemble.
Unlike the full-length Cby, N-Cby is found to be more soluble
athigherionicstrengths.ThisobservationsuggeststhatCbymay
undergo self-association under the NMR conditions used via its
putative C-terminal coiled-coil region. The elongated coiled-coil
structure formed by self-association may render Cby to tumble
significantly slower than a globular protein with similar molec-
ular weight, resulting in severe broadening of the NMR peaks from
this portion of the protein. Moreover, the association/dissocia-
tion of the coiled-coil structure on the intermediate NMR time
scale may also contribute to the signal broadening. It is note-
worthy that even though the self-association also increases the
overall tumbling of the N-terminal part of Cby, this segment of
the protein is highly flexible, and a large part of it does not
interact with the C-terminal region. Therefore, the NMR signals
from the N-terminus of Cby remain relatively sharp and
observable despite the self-association.
To test whether the signal broadening is due to the slow
molecular tumbling, a
1H-
15N TROSY-HSQC experiment (56),
which is designed for high molecular weight protein studies, was
performed on an
15N,
13C,
2H-labeled Cby sample. The spectrum
was compared to the one acquired with the regular
1H-
15N
HSQC experiment (Supporting Information Figure S4). Even
though the NMRsignalsoriginatingfrom the N-terminal partof
Cby are sharper in the TROSY-HSQC spectrum, most of the
signals from the C-terminal part of Cby are still unobservable.
The data suggest that the severe peak-broadening problem may
notbeduetotheslowmoleculartumblingcausedbydimerization
but more likely be the result of conformational exchange on
intermediate NMR time scale.
Multiple mutational variants of Cby have been created in an
attempt to circumvent the signal-broadening problem due to
conformational exchange and self-association occurring in the
FIGURE 3: Secondarystructurepropensity(SSP) scoresforCbyin0Murea(a)and4Murea(b)calculatedonthebasisoftheassigned
13CRand
13Cβ chemical shifts using the SSP program.720 Biochemistry, Vol. 50, No. 5, 2011 Mokhtarzada et al.
C-terminalregionoftheprotein.Thecoiled-coilmodel(Supporting
InformationFigureS1) illustratesthattherearetwoAsnresidues
(N81 and N88) in the a positions of the second and third heptad
repeats, positions that are usually occupied by hydrophobic
residues such as Leu, Ile, or Val. The presence of Asn residues
in the dimer interface is also found in some other coiled-coil
structures. It has been suggested that this confers specificity for
dimerization/oligomerization (57). Even though it is not energe-
tically favorable to bury a polar Asn in a hydrophobic interface,
the buried Asn may still form hydrogen bonding to promote
parallel assembly of the coiled coil (58).
The N88 residue in the third heptad repeat was mutated to a
leucine, with the aim of strengthening the dimerization interface
oftheC-terminalcoiled coil,whichcanin turnlead tothe reduction
ofmonomer-dimer exchange. AnN88L/L93Rdoublemutant has
alsobeenprepared,withtheL93Rmutationspecificallydesigned
to disrupt the possible hydrophobic patch formed by L90, L93,
and I97 on the surface of the coiled coil. Finally, a L77A/L91A
double mutant has also been included in this study. In a recent
publication, Mofunanya et al. demonstrate that the mutations of
these two leucine residues that are predicted to be critical for the
coiled-coil formation to alanine can disrupt the dimerization of
Cby (29).
Figure 5 shows the CD spectra of these three mutational
variants collected at 25 C, and their Tm values have been
determined by thermal denaturation. Compared to the wild-type
Cby, the N88L and N88L/L93R mutants display some minor
changesinthe CD spectra,and nosignificantchangeintheTmof
the protein was observed. On the other hand, the mutations of
both L77 and L91 to alanines lead to an ∼60% decrease in the
ellipticity at 222 nm and a dramatic decrease in Tm (from 70 to
18 C) compared to the wild-type. In addition, the Rs of N88L
and N88L/L93R mutants measured by DLS are very similar to
the value obtained for the wild-type Cby (∼30 A ˚ ), while the Rs
of L77A/L91A is significantly smaller (∼17 A ˚ ). The results
together suggest that mutation of these two key leucine residues
(L77 and L91) weakens the helical propensity and probably the
dimerization tendency of the coiled-coil region (29).
Despite the fact that these three mutational variants show
different extent of changes in the CD spectra, most of the NMR
signals from the C-terminal portion of these mutants are still not
observableintheir
1H-
15NHSQCspectra(datanotshown).The
results suggest that the conformational exchange that causes the
severe line broadening of NMR signals may be due to a more com-
plicated process than simply a monomer/dimer equilibrium. For
instance, a number of hydrophobic residues near the C-terminus
(residues 101-126) of Cby may very well also contribute to the
self-association of this protein. In fact, a synthetic peptide with
the sequence resembling only residues 70-100 of Cby and with
sextuple mutations (N81L/N88L/L90R/L93R/I97R/D100R)
incorporated to strengthen the dimer interface and to remove the
hydrophobicpatchonthecoiled-coilsurfaceisfoundtobehighly
soluble even at high pH and salt concentration. CD analysis
shows that this peptide adopts a highly stable coiled-coil con-
formationwith[θ]222/[θ]208≈1andTm∼95C(datanotshown).
BindingofCby toTC-1. Besidesthe structural characteriza-
tion of Cby in its free state, in this work, initial data on the
FIGURE 4: OligomerizationofCbystudiedbyESI-MS.TheESI-MSspectrumwasacquiredundernondenaturingconditionswith35μMCb yin
10 mM ammonium acetate, pH 5.
FIGURE 5: SecondarystructurecontentandstabilityofCbymutants.
Far-UV CD spectra of N88L (red), N88L/L93R (blue), and L77A/
L91A (green) mutational variants. Data were recorded in 10 mM
sodiumacetate(pH5)at25C with protein concentrations ∼35μM.Article Biochemistry, Vol. 50, No. 5, 2011 721
binding of Cby to its protein targets have been obtained. In a
previous study, we have shown that disordered TC-1 binds to
Cby via its highly helical C-terminal region (18). Here we have
carriedoutanNMRbindingexperimentbywhichunlabeledTC-1
was added to the
15N-labeled Cby. Panels a and b of Figure 6
show the
1H-
15N HSQC spectra of full-length Cby (60 μM) in
the absence and the presence of an excess amount (400 μM) of
TC-1,respectively.Noremarkablechangeinthechemicalshiftof
the signals from the N-terminal part of Cby is observed. The
result agrees withthe previous finding thatthe N-terminal region
of Cby is not directly involved in the binding to TC-1 (17).
Intriguingly, even though no dramatic peak shifts are observed,
the signals originating from the N-terminal portion of Cby
sharpened up remarkably upon addition of TC-1. Figure 6c
shows the relative intensity (IwithoutTC-1/IwithTC-1) of the assigned
Cby signals in the absence and the presence of unlabeled TC-1.
The result quantitatively demonstrates the sharpening of N-termi-
nal peaks of Cby upon binding to TC-1. This effect is more
pronouncedfor residues 20-50, which aredistant from the TC-1
binding site on Cby (17). Interestingly, the attenuations in peak
intensity become more dramatic at higher ionic strength. In the
presence of 100 mM ammonium acetate, a severe peak broad-
ening occurs in the
1H-
15N HSQC of Cby, and only a few peaks
were observed, probably due to the significant self-association of
the protein under this condition. The
1H-
15N HSQC spectrum,
however, changed dramatically when an excess amount of TC-1
was added to the sample. In the presence of TC-1, most of the
peaksfromthe N-terminalpartofCbyshowsignificantincreases
in intensity without outstanding changes in chemical shifts
(Supporting Information Figure S5a-c).
We have also performed
1H-
15N HSQC experiments on the
15N-labeled L77A/L91A double mutant samples (60 μM) with
differentamountsofunlabeledTC-1added(0,200,and400μM).
The results show that the L77A/L91A does not interact with TC-1
significantly as no considerable chemical shift changes have
been observed (data not shown). Further, there is no increase in
peak intensities upon addition of TC-1 as observed for the wild-
type. It is noteworthy that even though the L77A/L91A mutations
may weaken the dimerization, the double mutant may not neces-
sarilybind strongertoTC-1. Thisisbecause while L77A/L91A is
more monomeric, the mutations may also change the helical
contentoftheC-terminus(asindicatedbytheCDdata).Further,
thetwoleucinesinquestionmaybedirectlyinvolvedinbindingto
TC-1. These together may diminish the binding of L77A/L91A
to TC-1.
Disordered N-Cby Interacts with 14-3-3ζ. We have also
probed the interaction between the N-Cby and 14-3-3ζ using
NMR spectroscopy. According to Li et al. (10), upon phosphor-
ylation at serine 20 by Akt1, Cby can bind to the protein 14-3-3ζ
in the nucleus. In the present work, the phosphorylation of Cby
was mimicked via S20D site-directed mutagenesis. Compared to
thewild-typeofN-Cby,thesinglepointmutationdoesnotleadto
a dramatic change in the overall structure of the protein, judging
from the overlay of the
1H-
15N HSQC and CD spectra of the
wild-type and S20D mutant of N-Cby (Figure 7). The narrow
dispersion of
1H-
15N HSQC peaks indicates that N-Cby(S20D)
remainsdisordered,andthepeaksthatshowobservablechemical
shift changes upon mutation correspond to residues nearby the
mutation site (Figure 7a).
Backbone
15N spin-relaxation experiments have been per-
formed to probe the dynamics of the N-Cby(S20D). The results
of R1, R2, and steady-state
1H-
15N NOE measurements are
shown in Figure 8a-c. The relatively small R2 values for most of
the residues indicate that the N-Cby(S20D) is highly flexible
(Figure 8b). On the other hand, the observed positive NOE values
for residues 28-62 suggest that even though the protein is largely
unstructured, this particular segment of the protein is relatively
restricted in motion (Figure 8c). The result agrees with the SSP
analysis showing that residues 20-47 display mild helical pro-
pensity, while residues 48-62 may adopt β-strand structures in a
significant fraction of conformers in the ensemble (Figure 8d).
ComparedtotheN-Cby(WT),theS20Dmutationdoesnotcause
significant changes in the flexibility of the protein (Supporting
Information Figure S6a-c).
When the SSP scores of residues in N-Cby (Figure 8d) are
compared to the corresponding values in the full-length Cby
(Figure 3a), it is clear that the β-strand propensities of residues
50-62 increase upon truncation of the C-terminal part of the
protein.Thisexplainsourearlierobservationthatthemajorityof
peaks observed in the
1H-
15N HSQC of N-Cby can essentially
FIGURE 6: TitrationofunlabeledTC-1to
15N-labeledCby(in10mM
ammonium acetate, pH 5, 25 C). (a)
1H-
15NH S Q Cs p e c t r u mo f
60μM
15N-labeled Cby.(b)
1H-
15NHS QCsp ec tr umof60μM
15N-
labeledCbyþ400μMunlabeledTC-1.(c)Relativepeakintensitiesof
(a) compared to (b), with peak intensities in (b) normalized to 1.722 Biochemistry, Vol. 50, No. 5, 2011 Mokhtarzada et al.
overlay with the peaks observed in the spectrum of full-length
Cby, except for residues 50-63. The increase in β-strand/
extended propensity of N-Cby revealed by the SSP calculation
also qualitativelyagreeswiththe deconvoluted CD datashowing
that N-Cby has a higher percentage of β-structure compared to
that of the full-length protein (27% vs 10%). Interestingly,
residues 50-62 of full-length Cby also display higher β-strand
propensities (negative SSP scores) in 4 M urea. The results
suggest that the dimerization of Cby via its coiled-coil domain
may affect the secondary structure propensity and dynamics of
this region of the protein.
The compactness of the N-terminal Cby was also determined
by the pulsed field gradient NMR (PFG-NMR) diffusion
experiment via the hydrodynamic radius (Rh) measurement. By
using dioxaneas the reference molecule in the measurements, the
Rh of N-Cby(S20D) was determined to be 21.3 ( 0.8 A ˚ .T h i s
corresponds to a compaction factor (C)o f0 . 6 8( C has a value
between 0 and 1, with Cequal to 1 indicating a well-folded globular
protein), suggesting that even though the protein is disordered, a
significant residual structure is present (39).
To probe the interaction between disordered N-Cby(S20D)
and 14-3-3ζ, unlabeled 14-3-3ζ was titrated to
15N-labeled
N-Cby(S20D). Upon addition of 14-3-3ζ, the peaks on the
1H-
15N HSQC of N-Cby(S20D)are significantly broadened
out, albeit in a differential manner with some peaks affected
much more than the others (Figure 9a,b). The changes in the
relative intensity (Iwith14-3-3ζ /Iwithout14-3-3ζ) of all assigned
peaksareplottedversustheresiduenumberinFigure9c.The
severesignalbroadeningisexpectedtooccurwhentheflexible and
lower molecular weight N-Cby(S20D) binds to the dimeric
14-3-3ζ with molecular weight of ∼60 kDa. The differential
changes in peak intensity may suggest that some parts of
N-Cby(S20D) retain flexibility upon binding to 14-3-3ζ.
Moreover, some residues (T17, A19, S22, L27, T31, G37,
G41, S42, G49, Q50, A61) also demonstrate subtle chemical
shift changes upon addition of 14-3-3ζ, indicating that a
weak interaction may exist between these two proteins. We
are currently in the process of preparing phosphorylated
N-Cby for more detailed NMR characterization of its
interaction with 14-3-3ζ.
DISCUSSION
In this work, we have performed the first detailed structural
characterization of the 126-residue human Cby protein, a novel
antagonist of β-catenin in the Wnt signaling pathway (9), by
using NMR, CD, ESI-MS, and DLS techniques. The experi-
mental and bioinformatic analyses together clearly show that
Cby is partially disordered. While the N-terminal portion
(residues 1-63) of the protein is intrinsically unstructured, the
C-terminalregionisstronglyR-helical.Withinthishelicalregion,
a stablefour-heptad repeat coiled coil ispresentbetween residues
73 and 100. Importantly, our experimental data also add further
evidencethatCbyundergoesself-associationviathisputative
C-terminal coiled-coil domain. By performing gel filtration
chromatography and glutaraldehyde cross-linking analysis on
His-tagged Cby purified from HEK293T cells, Mofunanya et al.
demonstrated that Cby exists as a homodimer predominantly.
Further,theirresultsofcoimmunoprecipitationexperimentsalso
illustratedthatCbyformsanoligomer,whichisstableeveninthe
presence of 2 M NaCl or 2 M urea (29). These results very well
agree with the observations we reported here.
Besides the dimerization interface, the presence of hydropho-
bic residues on the solvent-exposed surface of the coiled coil,
namely, L90, L93, and I97, may possibly form a “hydrophobic
patch”, further enhancing the self-assocation of Cby. Indeed,
when thesesurface hydrophobicresiduesof the coiled-coilregion
were replaced with arginines in a synthetic peptide with the
sequence resembling residues 70-100 of Cby and with sextuple
mutations (N81L/N88L/L90R/L93R/I97R/D100R),the precipi-
tate-prone coiled coil becomes highly soluble even at the physio-
logical conditions of pH and salt concentration, without com-
promising the coiled-coil structure and stability. The fact that
Cby exists in equilibrium between monomeric and dimeric (or even
tetrameric) states very well explains the invisibility of NMR peaks
from the C-terminal half of the protein, since significant con-
formational exchange on the intermediate time scale may occur,
resulting in severe broadening of the signals. This also poses a
substantial challenge in the detailed structural characterization
of Cby.
While the C-terminal region of Cby is essential in mediating
the interactions with β-catenin (9), TC-1 (17), polycystin-2 (23),
importin-R (59), and NBPF1 (60), the N-terminal portion of the
protein is also important for target recognition (10, 59, 60).
Despite the lack of stable structure, results of SSP analysis and
relaxation measurements indicate that a mild helical propensity
exists in residues 20-50, while the rest of the N-Cby adopts
transient β-strand structure. Residual structures of IDPs have
been shown to play crucial roles in their interactions with
targets (61, 62). Indeed, the weak helical-like region of N-Cby
seems to mediate at least two currently known interrelated
FIGURE 7: Comparison of the wild-type N-Cby and the S20D
mutant.(a)
1H-
15NHSQCspectraofWTN-Cby(black)andS20D
mutant (red). Data were recorded in 10 mM sodium acetate (pH 5)
at 25 C with protein concentrations ∼300 μM. (b) Far-UV CD
spectra of WT N-Cby (black) and S20D mutant (red). Data were
recorded in 10 mM sodium acetate (pH 5) at 25 C with protein
concentrations ∼60 μM.Article Biochemistry, Vol. 50, No. 5, 2011 723
biological functions. First, by harboring the binding motif of
14-3-3proteins(residues16-22),thisregionofCbyisinvolvedin
the trimolecular complex formation with β-catenin and 14-3-
3ζ (10). Second, with a nuclear export signal located between
residues 21 and 29, this region of Cby is also crucial for the
interaction with CRM1 (chromosomal region maintenance pro-
tein 1) nuclear export receptor (59). Overall, the target interac-
tions carried out by the N- and C-terminal of Cby together
facilitatethedynamic nuclear-cytoplasmicshuttlingoftheprotein,
which in turn controls β-catenin subcellular distribution and
signaling (59).
The fact that the N- and C-terminal regions of Cby are
somewhat independent may be crucial for the protein to bind to
multiple targets via the distinct structural modules located in
these two segments. Yet the cooperativity of these two domains
allows them to work in unison in eliciting the protein functions.
Besides the aforementioned ternary complex with 14-3-3ζ and
β-catenin, Cbyhas also beensuggested toformanother trimolec-
ular complex with NBPF1 and clusterin, two candidate tumor
suppressors linked to neuroblastoma, via its C- and N-terminal
regions, respectively (60). Furthermore, based on the structural
information of Cby obtained here and the data from the literature, we
speculate that the mechanism Cby employs to block the interaction
between β-catenin and Tcf4 is through “steric masking”, which
involves both the N- and C-terminal regions of the protein,
instead of direct competition for an overlapping binding site. By
performing the in vitro pull-down assays, Takemaru et al. demon-
strated that the sequence of armadillo repeat 10 to the C-terminus
of β-catenin is essential for the binding to Cby (9). Surprisingly,
this binding site does not overlap with the Tcf4 binding site on
β-catenin, and yet Cby can inhibit the Tcf4/β-catenin interac-
tion.Onepossibleexplanation forthisphenomenon isthat,upon
binding to Cby, β-catenin undergoes significant conforma-
tionalchange,renderingtheproteinincapableofbindingTcf4.
However, the structures of the armadillo-repeat region of
β-catenin and the complexes it forms with a number of targets
have been determined (24, 26-28, 63-66). Judging from these
crystal structures, it does not seem that β-catenin undergoes
dramatic structural change upon binding to its targets. On the
basis of the result of our work, we speculate that Cby binds
to β-catenin via its C-terminal helical region and then masks
the Tcf4 binding site on β-catenin using its flexible N-terminal
portion. This mechanism is very similar to the “anchor-and-
kick” mechanism proposed by Graham et al. (64), which
ICAT (inhibitor of β-catenin and Tcf4) uses to inhibit the
interaction between β-catenin and Tcf4. The crystal structure
of the ICAT/β-catenin complex shows that ICAT binds to the
third helix of the armadillo repeat 12 of β-catenin via its
N-terminal three-helix bundle (63, 64). The “anchoring” of
the N-terminal ICAT onto β-catenin allows the extended
C-terminal tail of ICAT to interact with K312 and K435 of
β-catenin, two key residues that mediate the β-catenin/Tcf4
binding. Further experiments confirm that even though the
C-terminal tail of ICAT is not crucial for the binding to
β-catenin, it is essential for the inhibition of the β-catenin/Tcf4
interaction (64).
FIGURE 8: Structural and dynamical characterization of N-Cby(S20D). Backbone
15N relaxation measurements of N-Cby(S20D) in 10 mM
sodium acetate, pH 5, at 25 C. (a) Longitudinal relaxation rate (R1), (b) transverse relaxation rate (R2), and (c) steady-state
1H-
15NN O E .
(d) SSP scores for N-Cby(S20D) were calculated on the basis of the assigned
13CR and
13Cβ chemical shifts.724 Biochemistry, Vol. 50, No. 5, 2011 Mokhtarzada et al.
Further, the self-associating nature of Cby may also interplay
with its binding to targets. The incorporation of a coiled-coil
domain into the partially disordered Cby may increase its
stability in the absence of targets by self-association. In this
work, evidence for the binding of Cby to TC-1 is presented. The
sharpening of
1H-
15N HSQC signals from the N-terminus of
Cby upon addition of TC-1 suggests that the binding of TC-1 to
Cby may compete with the self-association process of Cby by
itself,therebyleadingtochangesintheflexibilityandtimescaleof
conformationalexchange,aswellasthemoleculartumblingofCby.
However, since Cby interacts with TC-1 also via its C-terminal
portion and the binding may not be very tight, signals from that
part of the protein are still broad, possibly due to the exchange
between the free and bound states on the intermediate time scale of
NMR. Further experiments are needed to dissect the detailed
molecular mechanism of binding between these two proteins.
Finally, the coexistence of intrinsic disorder with coiled coils
appears to be widespread. In a recent large-scale analysis of the
mouse intrinsically disordered proteome, Kriwacki and co-workers
discoveredthatasignificantnumberofpartiallydisorderedproteins
are predicted to also contain coiled-coil domains (67). Since both
disordered region and coiled-coil domain are known to mediate
protein-protein interactions, the result suggests that the combina-
tion of these two structural modules could facilitate disordered
proteins in assembling protein complexes via different modes of
interaction(67).Inlinewiththisproteomic/bioinformaticdiscovery,
several proteins with diverse biological functions have been struc-
turally characterized to contain long disordered regions and coiled-
coil motifs recently (68-73). For instance, human C/EBP
homologous protein (CHOP), which functions as a Wnt-signal-
ing inhibitor by binding to Tcf (74), has a disordered N-terminal
half while its C-terminal portion is R-helical and harbors a
putative coiled-coil domain (73). According to Singh et al., the
oligomerization of CHOP mediated by the N-terminal domain
has a direct implication in its biological function (73). As well,
prostate apoptosis response factor-4 (Par-4), a proapoptotic and
tumor suppressor protein, also employs both disordered region
and coiled-coil domain to interact with multiple targets (72).
Structural characterization by CD, DLS, and NMR revealed
that, similar to Cby, Par-4 is partially disordered with a
C-terminal coiled-coil domain mediating self-association. Intri-
guingly, over 50% of the residues in the full-length rat Par-4 are
also not observable in its
1H-
15NH S Q Cs p e c t r u m( 72). The
authors suggested that this may be due to the conformational
exchangebetweenapartiallyordered monomerandapredominantly
coiled-coil dimer (72, 75).
Theuniquestructuralanddynamicalpropertiesofintrinsically
disorderedproteinsarethereasonswhytheyarefrequentlyfound
to be involved in signaling pathways (76-78). The structural plas-
ticity allows them to interact with multiple targets with high
specificity and yet low binding affinity, which is crucial for the
rapid response to signaling events (79, 80). It is conceivable that
the inclusion of a coiled-coil domain with dimerization and target-
binding capabilities may radically expand the overall interaction
diversity of IDPs, allowing them to act as “hubs” in protein-
proteininteractionnetworks.Theever-expandingnumberofCby
partners to date may very well be a testament to this: polycystin-2,
TC-1, β-catenin, 14-3-3ζ, Akt1, NBPF1, clusterin, CRM-1, and
importin-R (9, 10, 17, 23, 59, 60). Detailed structural studies of
Cby and its interactions with targets will undoubtedly augment
our current understanding of the role of dual-module disordered
and coiled-coilproteinsinsignalingcascadesimplicatedinhealth
and disease.
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SUPPORTING INFORMATION AVAILABLE
The coiled-coil model of Cby, results of protein disorder
predictions, CD spectra of Cby at different urea concentrations,
FIGURE 9: TransientinteractionbetweenN-Cby(S20D)and14-3-3ζ.
(a)
1H-
15N HSQC spectra of ∼100 μM
15N-labeled N-Cby(S20D)
(25mMTris,pH7.0,125mMNaCl,1mMDTT,1mMEDTA,at25C)
in the absence (black) and the presence (red) of ∼300 μMu n l a b e l e d
14-3-3ζprotein.(b)Zoominofthecrowdedregionin(a).(c)Changes
inintensityofN-Cby(S20D)peaksuponadditionof14-3-3ζwiththe
intensities of the apo form normalized to 1.Article Biochemistry, Vol. 50, No. 5, 2011 725
TROSY-HSQC spectrum of Cby, NMR binding results of Cby
and TC-1 at high salt concentration, and backbone relaxation
data of N-Cby (WT). This material is available free of charge via
the Internet at http://pubs.acs.org.
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